Scientists at Northwestern Medicine report that fructose metabolism inside brain immune cells helps glioblastoma tumors grow in mice, and that removing a key fructose transporter slowed tumor ...
Scientists have made a “significant step” towards creating a blood test that detects brain tumours and monitors them in real time. The new test is over 90% accurate and could be used by GPs to pick ...
Social media posts and blog pages falsely claimed Thunberg had an aggressive form of glioblastoma, but no reputable outlet ...
Northwestern Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor metabolize fructose to suppress immune responses and promote tumor growth, reports a study ...
Despite decades of advancements in surgical techniques, chemotherapy, and radiotherapy, the clinical outlook for patients diagnosed with primary brain tumors remains sobering. Whi ...
The MarketWatch News Department was not involved in the creation of this content.-- Newly discovered drug leverages the power of Pattern Discovery Engine(TM) (PDE) and is an exten ...
Researchers in Manchester have developed an experimental method that shows potential for accurately detecting the most common and aggressive form of brain cancer in adults, known as glioblastoma, from ...
5d
Sonodynamic therapy is safe and well-tolerated in high-grade gliomas, first-in-human trial suggests
High-grade gliomas, especially glioblastoma (GBM) and others, remain among the most aggressive brain cancers, with few ...
Honing in on four markers for effective, patient-specific devices to combat glioblastoma.
Presented updated glioblastoma (“GBM”) data demonstrating durable survival and a favorable safety profile across Phase 1 and Phase 2 programs, ...
Phase 1 clinical trials evaluate the safety and dosage of proposed new treatments. Further research is needed to test the oncolytic virus therapy’s effectiveness and side effects. Work also continues ...
Glioblastoma is the most aggressive and deadliest form of brain cancer. Most patients survive only about a year after diagnosis, and just 5% make it to five years. Dr. Minesh P. Mehta is leading the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results